BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 6252815)

  • 1. Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.
    Oon CJ; Friedman MA
    Cancer Chemother Pharmacol; 1982; 8(2):231-5. PubMed ID: 6286165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan.
    Yu MW; Chang HC; Chen PJ; Liu CJ; Liaw YF; Lin SM; Lee SD; Lin SC; Lin CL; Chen CJ
    Int J Epidemiol; 2002 Oct; 31(5):1008-15. PubMed ID: 12435776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
    Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on the screening of primary hepatocellular carcinoma in selected high risk groups in the population using multiple tumour markers.
    Oon CJ; Yo SL; Chio LF; Chan SH
    Ann Acad Med Singap; 1980 Apr; 9(2):240-4. PubMed ID: 6252815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
    Wun YT; Dickinson JA
    Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-fetoprotein: diagnostic value in hepatic disorders].
    Kreczko S; Lipska A; Wysocka J
    Pol Merkur Lekarski; 2000 Jun; 8(48):420-3. PubMed ID: 10967924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers for hepatocellular carcinoma.
    Wu AH; Sell S
    Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.